---
document_datetime: 2023-09-21 20:57:35
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/synjardy-epar-all-authorised-presentations_en.pdf
document_name: synjardy-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 4.5498822
conversion_datetime: 2025-12-20 09:02:25.686578
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength         | Pharmaceutical form   | Route of administration   | Immediate Packaging                   | Pack size                                        |
|------------------|-------------------|------------------|-----------------------|---------------------------|---------------------------------------|--------------------------------------------------|
| EU/1/15/1003/001 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 10 x 1 tablets (unit dose)                       |
| EU/1/15/1003/002 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 14 x 1 tablets (unit dose)                       |
| EU/1/15/1003/003 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 30 x 1 tablets (unit dose)                       |
| EU/1/15/1003/004 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 56 x 1 tablets (unit dose)                       |
| EU/1/15/1003/005 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 60 x 1 tablets (unit dose)                       |
| EU/1/15/1003/006 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 100 x 1 tablets (unit dose)                      |
| EU/1/15/1003/007 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 120 (2 x 60 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/008 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 180 (2 x 90 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/009 | Synjardy          | 5 mg / 850 mg    | Film-coated tablet    | Oral use                  | blister                               | 200 (2 x 100 x1) tablets (unit dose) (multipack) |
| EU/1/15/1003/010 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | (PVC/PVDC/alu) blister (PVC/PVDC/alu) | 10 x 1 tablets (unit dose)                       |
| EU/1/15/1003/011 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 14 x 1 tablets (unit dose)                       |
| EU/1/15/1003/012 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister                               | 30 x 1 tablets (unit dose)                       |
| EU/1/15/1003/013 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 56 x 1 tablets (unit dose)                       |
| EU/1/15/1003/014 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 60 x 1 tablets (unit dose)                       |
| EU/1/15/1003/015 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 100 x 1 tablets (unit dose)                      |
| EU/1/15/1003/016 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 120 (2 x 60 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/017 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 180 (2 x 90 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/018 | Synjardy          | 5 mg / 1000 mg   | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 200 (2 x 100 x1) tablets (unit dose) (multipack) |
| EU/1/15/1003/019 | Synjardy          | 12.5 mg / 850 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu)                | 10 x 1 tablets (unit dose)                       |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength          | Pharmaceutical form   | Route of administration   | Immediate Packaging    | Pack size                                        |
|------------------|-------------------|-------------------|-----------------------|---------------------------|------------------------|--------------------------------------------------|
| EU/1/15/1003/020 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 14 x 1 tablets (unit dose)                       |
| EU/1/15/1003/021 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 30 x 1 tablets (unit dose)                       |
| EU/1/15/1003/022 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 56 x 1 tablets (unit dose)                       |
| EU/1/15/1003/023 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 60 x 1 tablets (unit dose)                       |
| EU/1/15/1003/024 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 100 x 1 tablets (unit dose)                      |
| EU/1/15/1003/025 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 120 (2 x 60 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/026 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 180 (2 x 90 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/027 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 200 (2 x 100 x1) tablets (unit dose) (multipack) |
| EU/1/15/1003/028 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 10 x 1 tablets (unit dose)                       |
| EU/1/15/1003/029 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 14 x 1 tablets (unit dose)                       |
| EU/1/15/1003/030 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 30 x 1 tablets (unit dose)                       |
| EU/1/15/1003/031 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 56 x 1 tablets (unit dose)                       |
| EU/1/15/1003/032 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 60 x 1 tablets (unit dose)                       |
| EU/1/15/1003/033 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 100 x 1 tablets (unit dose)                      |
| EU/1/15/1003/034 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 120 (2 x 60 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/035 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 180 (2 x 90 x 1) tablets (unit dose) (multipack) |
| EU/1/15/1003/036 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 200 (2 x 100 x1) tablets (unit dose) (multipack) |
| EU/1/15/1003/037 | Synjardy          | 5 mg / 850 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 90 x 1 tablets (unit dose)                       |
| EU/1/15/1003/038 | Synjardy          | 5 mg / 1000 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 90 x 1 tablets (unit dose)                       |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength          | Pharmaceutical form   | Route of administration   | Immediate Packaging    | Pack size                  |
|------------------|-------------------|-------------------|-----------------------|---------------------------|------------------------|----------------------------|
| EU/1/15/1003/039 | Synjardy          | 12.5 mg / 850 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 90 x 1 tablets (unit dose) |
| EU/1/15/1003/040 | Synjardy          | 12.5 mg / 1000 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC/alu) | 90 x 1 tablets (unit dose) |